Projecten
MERIT: Mutanome Engineered RNA Immuno-Therapy. Vrije Universiteit Brussel
EXPANDing Immune Cells and their Tumor Antigens during checkpoint immunotherapy Vlaams Instituut voor Biotechnologie
CIRCULATING TUMOR DNA AS AN EPIGENETIC BIOMARKER FOR TUMOR RESPONSE’ — ‘INITIATOR’ - ERC POC Vlaams Instituut voor Biotechnologie
RESISTANCE UNDER COMBINATORIAL TREATMENT IN ER+ AND ER- BREAST CANCER.’ — ‘RESCUER’ Vlaams Instituut voor Biotechnologie
Gezondheidseffecten van cardiale fluoroscopie en moderne radiotherapie bij pediatrie KU Leuven
The increasing use of radiation-associated diagnostic and therapeutic procedures have contributed to the improvements of early diagnosis and survival of paediatric patients. While benefits to the patient outweigh the radiation associated risk, the late effects of exposure of children are particularly important to understand in populations with increased survival.
The HARMONIC project builds on close collaboration between scientific and ...
EurOPDX Gedistribueerde infrastructuur voor onderzoek naar van patiënten afkomstige kanker xenograften KU Leuven
Counteracting high attrition rates in oncology drug development and providing optimal therapeutic management of cancer patients require preclinical models that properly recapitulate the complexity and diversity of human tumours. Patient-derived tumour xenografts (PDXs), established by transplanting tumour fragments into immunodeficient mice, are being widely embraced by the scientific community as preclinical tools for target and biomarker ...
'Advancing a Precision Medicine Paradigm in metastatic Colorectal Cancer: Systems based patient stratification solutions’ — ‘COLOSSUS’ Vlaams Instituut voor Biotechnologie
Transformeren van magnetische resonantie spectroscopie in een klinische tool. KU Leuven
In vivo Magnetic Resonance Spectroscopy and Spectroscopic Imaging (MRS(I)) are unique, indispensable techniques for non-invasive metabolic imaging. Important areas where MRS(I) can make a difference are oncology and neurology, where metabolic changes due to, e.g., tumour formation, can be detected earlier and more sensitively than with morphological imaging modalities alone. Despite its huge proven potential, MRS(I) is not yet a routine ...